Immediate Impact
50 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
2024 Standout
Works of Lucy Yan being referenced
Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine
2017
Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor–Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid Tumors
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Lucy Yan | 9 | 49 | 73 | 126 | 117 | 13 | 312 | |
| Hong-Bo Huan | 1 | 58 | 134 | 76 | 28 | 13 | 314 | |
| Ching Hsu | 19 | 105 | 76 | 30 | 23 | 22 | 345 | |
| Miren Aizpurua | 1 | 11 | 31 | 23 | 82 | 17 | 316 | |
| Jun Zhao | 5 | 48 | 107 | 38 | 17 | 23 | 356 | |
| Wenting Hou | 1 | 38 | 138 | 50 | 11 | 16 | 331 | |
| Claire Calmel | 20 | 81 | 143 | 12 | 43 | 19 | 312 | |
| Jen‐Yea Chang | 157 | 19 | 71 | 17 | 16 | 9 | 327 | |
| Yoshitaka Ohmachi | 11 | 81 | 114 | 27 | 24 | 12 | 331 | |
| Nobuyoshi Iinuma | 8 | 58 | 125 | 42 | 14 | 11 | 280 | |
| Joan Raouf | 7 | 53 | 123 | 23 | 16 | 16 | 321 |
All Works
Loading papers...